Conferencias


Eye Tracking and Gating System for Proton Therapy of Uveal Melanomas
Presenting Author/Institution: Dongho Shin, Proton Therapy Center, National Cancer Center, Korea Background Ocular melanoma is an uncommon malignancy, usually occurring in the uvea of the eye. For asymptomatic patients and ..
Interferon Therapy Delays Disease Recurrence and Prolongs Survival in Patients with Resected Melanoma
Jean-Jacques Grob, MD, professor dermatology, University of Marseille, Hopital Sante-Marguerite (Marseille, France), presented a study of interferon alfa-2a as adjuvant therapy in patients with resected (surgically removed) early stage melanoma. ..
Cancer Vaccine Triggers Immune System to Recognize Melanoma
Unlike vaccines that are used to prevent infectious disease, cancer vaccines attempt to stimulate the body's own immune system to recognize cancer cells as foreign and destroy them. These researchers ..
Melanoma Patients Could be Spared Radical Surgery by Sentinel Node Mapping
A technique called "sentinel node mapping" can accurately diagnose the minority of patients whose melanoma has spread, while saving the majority from radical lymph node dissection surgery, according to results ..
The 6th World Conference on Melanoma
Conference Dates: September 2 - 9, 2005 Conference Location: Vancouver Convention & Exhibition Centre Sponsoring Group: WHO Melanoma Programme Conference Web Page URL: www.worldmelanoma.com Topics Covered: melanoma: surgery, clinical diagnosis, ..
The Fourth Annual Wallace H. Clark, Jr. Lectureship in Cutaneous Oncology and Melanoma Symposium
Conference Dates: Thursday, February 6, 2003 Conference Location: Philadelphia, Pennsylvania Sponsoring Group: University of Pennsylvania Abramson Cancer Center and the Department of Dermatology Topics Covered: Melanoma, cutaneous oncology, and general ..
First International Melanoma Research Congress
Conference Dates: June 21-24, 2003 Conference Location: Wyndham Franklin Plaza Hotel in Philadelphia Sponsoring Group: Foundation for Melanoma Research Conference Web Page URL: www.foundationformelanomaresearch.org Topics Covered: Immunology, Epidemiology, Biology, Molecular ..
The 1st European Conference: Perspectives in Melanoma Management
Conference Dates: October 9-11, 2003 Conference Location: Amsterdam, The Netherlands Sponsoring Group: Imedex. Under the auspices of EORTC Conference Web Page URL: www.imedex.com/announcements/emelanoma03.html Topics Covered: EORTC Melanoma Group Program Scientific ..
Melanoma Regional Symposium
Conference Dates: October 4, 2003 Conference Location: Stabile Research Building at Moffitt Cancer Center, Tampa, Florida Sponsoring Group: Moffitt Cancer Center Conference Web Page URL: www.moffitt.usf.edu Topics Covered: Melanoma, plastic ..
The Role Of Sentinel Lymphadenectomy In Thin Cutaneous Melanomas
Presenter: Richard J. BleicherPresenter's Affiliation: The John Wayne Cancer Institute, Santa Monica, CAType of Session: ScientificBackground The sentinel lymph node (SLN) biopsy is revolutionizing the surgical management of primary malignant ..
Long Term Survival Of Stage II And III Melanoma Patients With Respect To Serial Tyrosinase RT-PCR Testing In Peripheral Blood
Presenter: Christiane A VoitPresenter's Affiliation: University of Mainz, Mainz, GermanyType of Session: ScientificBackground Melanoma has a high metastatic potential even in small primary lesions, and an early distinction between localized ..
Perspectives in Melanoma
Conference Dates: September 23-25, 2004 Conference Location: Berlin, Germany Sponsoring Group: Imedex, Inc. Conference Web Page URL: www.imedex.com/calendars/oncology.htm Registration Information: Online at www.imedex.com; Tel: +1 770 751 7332; Fax: +1 ..
Focus on Melanoma
Conference Dates: March 31, 2005 Conference Location: University of Pennsylvania Biomedical Research Building II/III, Philadelphia PA Sponsoring Group: The Abramson Cancer Center of the University of Pennsylvania Conference Agenda: 2nd ..
Long-term survival results of a randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients with advanced malignant melanoma
Presenter: J.M. KirkwoodPresenter's Affiliation: University of Pittsburgh Cancer InstituteType of Session: ScientificBackground Oblimersen sodium (Genasense, G3139) is an antisense oligonucleotide that selectively targets and specifically binds bcl-2 mRNA resulting in decreased ..
Canadian Melanoma Conference: Research Frontiers
Conference Dates: Thursday, March 2, 2006 to Monday, March 6, 2006 Conference Location: The Fairmont Banff Springs Hotel, Banff, Alberta Sponsoring Group: Alberta Cancer Board Conference Web Page URL: http://www.buksa.com ..
3rd Annual Focus on Melanoma
Date: Friday, May 12, 2006 8:30 AM - 4:30 PM Location: Hilton Hotel, City Line Avenue, Philadelphia, PA Conference Information: Please view the Conference Brochure [PDF]. Who Should Attend: Patients ..
8th Annual Wallace H. Clark, Jr., MD Lectureship in Cutaneous Oncology & Melanoma Symposium
Conference Dates: Thursday, March 29, 2007 Conference Location: University of Pennsylvania Biomedical Research Building II/III, Ground Floor Auditorium, Curie Blvd., and Osler Way, Phila., PA Sponsoring Group: Penn's Department of ..
2007 International Melanoma Congress
Conference Dates: November 1-4, 2007 Conference Location: New York Marriott Financial Center, New York, NY Conference Web Page URL: http://www.melanomacongress07.net/main/index.php Topics Covered: Why melanocytes develop into melanoma Why are melanomas ..
Melanoma 101 Teleconference
Conference Dates: Thursday October 18, 2007, 12-1PM Conference Location: Free Teleconference Sponsoring Group: Melanoma Research Foundation Conference Web Page URL: http://www.melanoma.org/Contents.aspx?TeleConfId=218&ContentId=218&Categoryid=99 Topics Covered: Topics to be covered include: Melanoma risk ..
Fourth Annual Focus on Melanoma
Conference Dates: May 11, 2007 Conference Location: Hilton Hotel, City Line Avenue, Philadelphia, PA Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania Who Should Attend: Patients and families ..
Sentinel Lymph Node Biopsy Improves Survival Among SEER Patients with Melanoma
Presenter: Gimotty P. Presenter's Affiliation: University of Pennsylvania Type of Session: Scientific Background Regional lymph node metastases increase the risk of melanoma-specific death. Sentinel lymph node biopsy (SLNB) provides prognostic ..
Proton Therapy of Uveal Melanomas: Thirty years Experience
Presenter: Evangelos Gragoudas, MD Affiliation: Massachusetts Eye and Ear Infirmary Introduction Uveal melanoma is a rare malignancy with a rate in the United States of 6 cases per million per ..
Eleventh Annual Wallace H. Clark Jr., MD Lectureship in Cutaneous Oncology Melanoma Symposium
Conference Dates: April 29, 2010 Conference Location: University of Pennsylvania, Biomedical Research Building II/III, Ground Floor Auditorium, Curie Blvd.  Osler Circle, Philadelphia, PA Sponsoring Group: University of Pennsylvania School of ..
Proton radiation therapy of ocular melanoma at PSI - long-term clinical exam
Presenter: G. Goitein, A. Schalenbourg, J. Verwey, A. Bolsi, C. Ares, L. Chamot, E. Hug, L. ZografosPresenter's Affiliation: Paul Scherrer Institute (PSI) Villigen, Switzerland Type of Session: ScientificBackground There are ..
Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy: Results of an Intergroup Randomized Trial (TROG 02.01/ANZMTG 01.02)
Presenter: B. BurmeisterPresenter's Affiliation: Princess Alexandra Hospital, Brisbane, AustraliaType of Session: PlenaryBackground Approximately 80% of patients with melanoma who undergo lymphadenectomy have high-risk features. Of these high risk patients, approximately ..
A phase III, randomized, double-blind, multicenter study comparing monotherapy with ipilimumab or gp100 peptide vaccine and the combination in patients with previously treated, unresectable stage III or IV melanoma
Presenter: Steven O'Day, The Angeles Clinic and Research Institute, Los Angeles, CA. Background Advanced melanoma (Stage III/IV) has an increasing global incidence. Many patients are diagnosed at a relatively young ..
Twelfth Annual Wallace H. Clark Jr., MD Lectureship in Cutaneous Oncology & Melanoma Symposium
Conference Date: April 7, 2011, 8:30 AM - 12:00 PM Conference Location: University of Pennsylvania, Biomedical Research Building II/III, Ground Floor Auditorium, Curie Blvd. Osler Circle, Philadelphia, PA Conference Brochure: ..
Focus on Melanoma Conference
Dates: May 13, 2011, 8am - 3pm Location: Hilton Hotel, 4200 City Avenue, Philadelphia, PA Sponsoring Group: Abramson Cancer Center Web Page URL: http://www.penncancer.org/events.cfm?type=1=view%3Devent%26eventid%3D92646431 Topics Covered: HOLD THE DATE The ..
A population-based, case-control study of MC1R variants, ultraviolet light exposure, and melanoma
Presenter: D. Polsky Presenter's Institution: New York University Background/Introduction It is well known that ultraviolet light (UV) exposure is associated with increased melanoma risk. In addition, several different genes have ..
Melanoma as a subsequent neoplasm in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
Presenter: A. S. Pappo Presenter's Institution: St. Jude Children's Research Hospital, Memphis, TN Background Survivors of childhood cancer are at increased risk of developing secondary malignant neoplasms (SMN). Generally speaking, ..
Phase III randomized, open-label, multicenter trial (BRIM3) comparing BRAF inhibitor vemurafenib with dacarbazine (DTIC) in patients with V600EBRAF-mutated melanoma
Presenter: P. B. Chapman Presenter's Institution: Memorial Sloan Kettering Cancer Center Background Dacarbazine (DTIC) was approved for melanoma in 1975; the overall response rate has been reported at 7-12% and ..
Phase III randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) versus DTIC alone as first-line treatment in patients with unresectable stage III or IV melanoma
Presenter: Wolchok Presenter's Affiliation: Memorial Sloan Kettering Cancer Center, New York, NY Background Metastatic melanoma is an aggressive and deadly disease with limited treatment options. The incidence of metastatic melanoma, ..
7th Annual Focus on Melanoma Conference: What’s New in Melanoma and News You Can Use
Date/Time: Friday, May 14, 2010, 7:30am – 2:30pm Location: Hilton Hotel 4200 City Avenue Philadelphia, PA Audience: Open to All   Sponsor: Cancer - Abramson Cancer Center   Cost: This event is ..
English

I Wish You Knew

Skin cancer 101

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información